查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1988444

血管内视镜设备市场：按产品类型、技术、应用和最终用户划分 - 2026-2032年全球市场预测

Angioscope Device Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，血管内内视镜设备市场价值将达到 2.847 亿美元，到 2026 年将成长至 3.0498 亿美元，到 2032 年将达到 4.5051 亿美元，复合年增长率为 6.77%。

主要市场统计数据
基准年 2025 2.847亿美元
预计年份：2026年 3.0498亿美元
预测年份 2032 4.5051亿美元
复合年增长率 (%) 6.77%

简要概述血管内内视镜设备的临床和操作引入：概述其手术价值、设备特性以及在医疗环境中采用的趋势。

血管内视镜设备正逐渐成为微创诊断和治疗的关键工具，在多个临床专科领域中兼顾可视化需求和手术效率。这些设备结合了光学技术、影像处理硬体和人体工学设计，使临床医生能够更精准地进入血管和管腔解剖结构，进行可视化观察和介入。随着手术技术的进步和医疗服务向门诊及社区医疗机构转移，血管内视镜因其缩短手术时间、提高诊断准确性和增强患者管​​理能力而日益受到重视。

技术进步、医疗转型和相关人员的期望如何重塑血管内视镜的设计、部署流程和采购重点。

血管内视镜领域正经历着一场变革，其驱动力来自于技术的进步、操作流程的改进以及相关人员期望的不断变化。高解析度成像和光学技术的进步提高了诊断的可靠性，而小型化和改进的驱动系统则使得医生能够进入更远端、更复杂的解剖结构，从而拓展了治疗应用。这些技术进步也正在重塑采购标准，因为医院和专科医疗中心需要能够与更广泛的影像和记录基础设施整合的互通性操作系统。

对于血管内视镜领域的相关人员，近期美国关税变化对采购经济性、供应链策略和产品定位的实际影响。

美国近期关税趋势和贸易政策的变化，为医疗设备製造商和医疗保健系统的采购和供应计画带来了新的变数。关税会增加进口零件和成品的整体成本，迫使製造商重新思考筹资策略、合约结构和定价模式。这些变化往往会加速关于区域供应多元化、关键零件国内采购以及本地组装的讨论，以减轻贸易中断的影响。

将设备外形、临床应用、终端用户环境和成像技术与可操作的商业化方案连结起来的实用细分见解。

以细分市场主导导向的策略能够最清楚地展现整个血管内视镜市场中产品特性与临床和商业性优先事项的观点度。根据产品类型，市场可分为软式和硬式两种。软式血管内视镜又可细分为可重复使用型和一次性使用型，硬式血管内视镜同样可细分为可重复使用型和一次性使用型。这种二分法指南着关于生命週期规划、再处理投入以及单次手术成本的讨论，因此，製造商必须清晰阐述资本主导和耗材主导模式之间的权衡取舍。

制定区域策略，协调美洲、欧洲、中东和非洲以及亚太地区的监管环境、医疗服务提供者能力和商业模式。

区域趋势影响整个血管内视镜器械市场的采用率、监管应对路径和市场进入策略。在美洲，大规模的集中和完善的门诊手术基础设施往往会加速临床检验进程，并促进新技术的快速应用。然而，买家需要与临床结果和营运效率相关的明确价值提案。在欧洲、中东和非洲，不同的管理体制和报销方式要求进行个人化的证据生成，并采用灵活的商业模式，以适应各国特定的采购惯例和价格敏感度。

决定血管内视镜生态系中成熟企业、专业光学公司和新兴参与企业成功的竞争和策略差异化因素。

血管内视镜器材领域的竞争动态由多家公司共同塑造，包括成熟的医疗设备製造商、专业的光学仪器製造商以及专注于数位化整合和一次性便捷性的新兴技术公司。主要企业凭藉着深厚的临床证据、涵盖诊断和治疗应用的广泛产品系列，以及提供全面服务和培训方案的能力脱颖而出，从而减少临床实践中的摩擦。此外，投资于模组化平台和配件生态系统的公司正在增加客户的转换成本，有助于提高客户维繫。

为行业领导者提供切实可行的、高优先级的建议，以协调临床证据、产品系列、供应弹性和经营模式，以实现永续成长。

寻求可持续成长的行业领导者应优先考虑整合产品设计、临床证据生成和客户体验的综合方法。首先，投资于能够产生可操作证据的临床伙伴关係，以证明流程效率、诊断准确性和以患者为中心的疗效，同时确保研究设计能够反映采购委员会和报销利益相关人员的需求。其次，透过平衡可重复使用产品和一次性产品，优化产品系列，以满足医院、门诊中心和专科诊所等不同终端用户的偏好，同时简化再处理和物流流程，以降低整体拥有成本。

透过结合设备架构分析、临床文献整合和相关人员访谈，我们透过高度透明的基于三角测量的调查方法，产生可操作的策略见解。

本研究采用三角测量法，结合设备架构分析、临床文献整合和相关人员访谈，深入洞察血管内视镜市场趋势。设备架构分析检验了光学系统、影像处理流程、影像重处理需求和配件生态系统，揭示了不同产品类别和技术之间的功能权衡。临床文献整合优先考虑同侪审查的手术结果、对比影像学研究和专业学会指南，以阐明诊断和治疗效用。

综合考虑技术、医疗保健服务、监管和商业性因素，得出决定血管内视镜广泛应用和长期价值实现的明确结论。

总之，血管内视镜设备正处于光学技术创新、手术流程改善和医疗服务模式演变的策略性交会点。影像技术和设备人体工学的进步正在拓展其临床应用范围，而医疗服务模式的变革正在重塑人们对一次性产品和可重复使用产品的偏好。价格趋势和供应链因素也为采购和定价策略增添了新的维度，这要求製造商和采购者都进行积极主动的规划。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 血管内内视镜设备市场：依产品类型划分

  • 灵活的
  • 硬度

第九章：血管内内视镜设备市场：依技术划分

  • 高解析度
    • 4K
    • 全高清
  • 标准定义
    • SVGA
    • VGA

第十章 血管内内视镜设备市场：依应用划分

  • 诊断
    • 消化器官系统
    • 呼吸系统
    • 泌尿系统
  • 治疗
    • 循环系统
    • 消化器官系统
    • 呼吸系统

第十一章 血管内内视镜设备市场：依最终用户划分

  • 门诊手术中心
  • 医院
  • 专科诊所

第十二章 血管内内视镜设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 血管内内视镜设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 血管内内视镜设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国：血管内内视镜设备市场

第十六章 中国：血管内视镜器械市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Canon Medical Systems
  • Cardinal Health
  • Cook Medical
  • Fujifilm Holdings Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Johnson & Johnson Services, Inc.
  • Karl Storz
  • LivaNova PLC
  • Medtronic PLC
  • Olympus Corporation
  • Philips Healthcare
  • Shimadzu Corporation
  • Siemens Healthineers
  • Smith & Nephew PLC
  • Stryker Corporation
  • Terumo Corporation
  • Vena Medica
  • Zimmer Biomet
Product Code: MRR-6B0EA07975A0

The Angioscope Device Market was valued at USD 284.70 million in 2025 and is projected to grow to USD 304.98 million in 2026, with a CAGR of 6.77%, reaching USD 450.51 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 284.70 million
Estimated Year [2026] USD 304.98 million
Forecast Year [2032] USD 450.51 million
CAGR (%) 6.77%

A concise clinical and operational introduction to angioscope devices outlining procedural value, device characteristics, and adoption dynamics across care settings

Angioscope devices have emerged as pivotal tools in minimally invasive diagnostics and therapeutics, bridging visualization needs with procedural efficiency across multiple clinical specialties. These devices combine optics, imaging hardware, and ergonomics to enable clinicians to access, visualize, and intervene within vascular and luminal anatomy with improved precision. As procedural techniques evolve and care shifts toward outpatient and ambulatory settings, angioscopes are increasingly evaluated for their ability to reduce procedure time, improve diagnostic yield, and enhance patient throughput.

Clinicians and health system leaders assess these devices not only on imaging clarity and maneuverability but also on lifecycle considerations such as reprocessing workflows, single-use adoption, and integration with existing imaging stacks. Simultaneously, manufacturers navigate an environment shaped by regulatory scrutiny, reimbursement variability, and supply chain resilience. From a payer and provider perspective, the balance between upfront device cost and downstream clinical value is central to adoption decisions.

Transitioning from concept to routine use requires robust clinical evidence, seamless training pathways, and thoughtful deployment plans that reduce friction at the point of care. The introduction of higher-definition imaging options and modular device families is expanding clinical applicability while also demanding clear demonstration of incremental benefit to justify procurement and operational changes.

How technological advancement, care migration, and stakeholder expectations are reshaping angioscope design, adoption pathways, and procurement priorities

The angioscope landscape is undergoing transformative shifts driven by technological refinement, procedural migration, and evolving stakeholder expectations. High-definition imaging and advancements in optics are elevating diagnostic confidence, while miniaturization and improved drive systems enable access to more distal and tortuous anatomy, expanding therapeutic indications. These technological strides are also reshaping procurement criteria, as hospitals and specialty centers demand interoperable systems that align with broader imaging and documentation infrastructures.

Concurrently, care delivery is migrating toward ambulatory surgical centers and outpatient specialty clinics, prompting device manufacturers to prioritize portability, simplified sterilization workflows, and rapid turnover. This shift places renewed emphasis on single-use options where infection control, turnaround times, and predictable per-procedure economics are paramount. At the same time, reusable architectures are being redesigned for streamlined reprocessing and durable performance to retain relevance in high-volume hospital settings.

Stakeholder expectations are changing too: clinicians expect devices that reduce cognitive load and integrate seamlessly with digital health records, while hospital administrators require clear evidence of operational efficiency and cost-effectiveness. Regulatory trends toward higher evidentiary standards and reimbursement scrutiny are converging with supply chain resilience imperatives, making agility and clinical collaboration essential competitive differentiators.

Practical implications of recent United States tariff shifts on procurement economics, supply chain strategies, and product positioning for angioscope stakeholders

Recent tariff developments and trade policy shifts in the United States have introduced new variables into procurement and supply planning for medical device manufacturers and health systems. Tariffs can increase landed costs for imported components or finished devices, prompting manufacturers to reassess sourcing strategies, contract structures, and pricing models. These shifts often accelerate conversations about regional supply diversification, onshoring of critical components, and local assembly to mitigate exposure to trade disruptions.

Providers and group purchasing organizations may respond by tightening purchasing specifications, seeking alternative suppliers, or negotiating longer-term contracts to lock in pricing. This in turn impacts product roadmaps as manufacturers weigh the economics of producing multiple device configurations tailored to different regulatory and tariff regimes versus standardizing platforms to achieve scale. Additionally, increased costs related to tariffs can influence the relative attractiveness of single-use versus reusable devices, since per-procedure economics are sensitive to both component costs and downstream processing expenses.

From a strategic perspective, transparency in landed cost modeling, scenario planning, and proactive engagement with supply chain partners are essential. Manufacturers that communicate pricing drivers clearly and collaborate on inventory and logistics strategies will be better positioned to retain customer relationships while navigating the implications of tariff changes on product availability and procurement timelines.

Actionable segmentation insights linking device form factor, clinical application, end user environment, and imaging technology to practical commercialization choices

Segmentation-driven strategies provide the clearest lens for aligning product features with clinical and commercial priorities across the angioscope landscape. Based on product type, the market differentiates between flexible and rigid devices, with flexible angioscopes further categorized into reusable and single-use variants and rigid angioscopes likewise segmented into reusable and single-use options. This bifurcation informs lifecycle planning, reprocessing investments, and per-procedure cost discussions, making it essential for manufacturers to articulate the trade-offs between capital equipment and consumable-led models.

Based on application, device use is commonly divided between diagnostic and therapeutic categories, where diagnostic applications encompass gastrointestinal, respiratory, and urological use-cases and therapeutic applications span cardiovascular, gastrointestinal, and respiratory interventions. Devices designed for diagnostic work often prioritize high-fidelity visualization and ease of navigation, whereas therapeutic platforms emphasize working channel compatibility, instrument stability, and torque control for interventional maneuvers.

Based on end user, adoption patterns diverge across ambulatory surgical centers, hospitals, and specialty clinics, each of which presents distinct procurement cycles, procedural volumes, and service-level expectations. Finally, based on technology, angioscopes are differentiated between high definition and standard definition systems, where high definition further subdivides into 4K and Full HD offerings and standard definition breaks down into SVGA and VGA classes. These resolution tiers drive clinician perception of diagnostic value and influence integration requirements with existing imaging ecosystems.

Regional strategies that reconcile regulatory variability, provider capabilities, and commercial models across the Americas, Europe Middle East & Africa, and Asia Pacific landscapes

Regional dynamics shape adoption velocity, regulatory pathways, and go-to-market tactics across the angioscope device landscape. In the Americas, a concentration of large health systems and established ambulatory surgery infrastructures often accelerates clinical validation efforts and supports rapid deployment of new technologies, yet purchasers demand clear value propositions tied to clinical outcomes and operational efficiency. In Europe, Middle East & Africa, heterogeneous regulatory regimes and varying reimbursement approaches require tailored evidence generation and flexible commercial models that account for country-specific procurement norms and pricing sensitivities.

In the Asia-Pacific region, a diverse mix of mature markets and rapidly developing healthcare systems creates both scaling opportunities and complexity. Providers in high-growth markets may prioritize cost-effective single-use options to reduce capital barriers and reprocessing burdens, whereas centers of excellence in more developed economies may adopt premium high-definition systems to support advanced therapeutic programs. Across all regions, logistical considerations such as distribution networks, clinical training capacity, and after-sales service capabilities are decisive factors in successful deployments.

Therefore, regional strategies must blend clinical evidence, pricing models, and service architectures that reflect local regulatory expectations, reimbursement environments, and provider capabilities to ensure sustainable adoption and long-term utilization.

Competitive dynamics and strategic differentiators that define success for established firms, specialized optics companies, and emerging entrants in the angioscope ecosystem

Competitive dynamics in the angioscope device sector are shaped by a mix of established medical device firms, specialized optics companies, and emerging technology entrants that prioritize digital integration or single-use convenience. Leading players differentiate through depth of clinical evidence, breadth of product portfolios that span both diagnostic and therapeutic applications, and the ability to provide comprehensive service and training packages that reduce friction at the point of care. In addition, firms that invest in modular platforms and accessory ecosystems create switching costs that support customer retention.

Investment in higher-definition imaging, interoperability with hospital information systems, and partnerships with instrument OEMs are common strategies to expand addressable use cases. New entrants often pursue niche clinical segments or disruptive distribution models to gain footholds, while incumbents leverage scale advantages in manufacturing and regulatory experience to maintain market access. Across the competitive landscape, strategic alliances, licensing agreements, and targeted acquisitions frequently accelerate capability expansion and geographic reach.

Ultimately, companies that combine clinical collaboration, robust post-market surveillance, and transparent economic modeling are best positioned to build trust with providers and payers, enabling broader clinical adoption and deeper integration into procedural workflows.

Practical and prioritized recommendations for industry leaders to align clinical evidence, product portfolios, supply resilience, and commercial models for sustainable growth

Industry leaders seeking durable growth should prioritize an integrated approach that aligns product design, clinical evidence generation, and customer experience. First, invest in clinical partnerships that produce pragmatic evidence demonstrating procedural efficiency gains, diagnostic accuracy improvements, and patient-centered outcomes, while ensuring that study designs reflect the needs of purchasing committees and reimbursement stakeholders. Second, optimize product portfolios by balancing reusable and single-use offerings to meet diverse end-user preferences across hospitals, ambulatory centers, and specialty clinics, while streamlining reprocessing and logistics to reduce total cost of ownership.

Third, strengthen supply chain resilience through diversified sourcing, regional assembly options, and collaborative inventory management with key customers to mitigate exposure to trade policy volatility. Fourth, enhance commercial impact by developing interoperable systems that integrate with electronic health records and imaging archives, accompanied by scalable training programs and remote support capabilities that lower adoption barriers. Finally, adopt flexible pricing and contracting models that reflect regional reimbursement environments and provider procurement cycles, enabling pilots and phased rollouts that demonstrate value before larger commitments.

By operationalizing these priorities with cross-functional governance and measurable KPIs, industry leaders can convert innovation into sustained clinical and commercial outcomes.

A transparent triangulated methodology blending device architecture analysis, clinical literature synthesis, and stakeholder interviews to produce actionable strategic insights

This research applied a triangulated methodology combining device architecture analysis, clinical literature synthesis, and stakeholder interviews to generate robust insights on the angioscope landscape. Device architecture analysis examined optical systems, imaging pipelines, reprocessing requirements, and accessory ecosystems to map functional trade-offs across product classes and technologies. Clinical literature synthesis prioritized peer-reviewed procedural outcomes, comparative imaging studies, and guidance from specialty societies to contextualize diagnostic and therapeutic utility.

Stakeholder interviews included clinicians, procurement leaders, biomedical engineers, and distribution partners to surface real-world adoption barriers, training needs, and service expectations. These qualitative inputs were integrated with secondary sources to validate trends and to identify inflection points related to technology, reimbursement, and supply chain dynamics. Continuous validation loops were used to reconcile divergent perspectives and to ensure findings reflected practical, implementable strategies.

Where appropriate, sensitivity analyses and scenario planning were employed to explore the implications of cost, regulatory, and tariff variability on procurement and deployment decisions. The methodology emphasized transparency in assumptions and reproducibility of findings to support confident strategic decision-making.

A decisive conclusion synthesizing technology, care delivery, regulatory, and commercial drivers that will determine angioscope adoption and long term value realization

In conclusion, angioscope devices occupy a strategic intersection of optical innovation, procedural evolution, and shifting care delivery models. Technological improvements in imaging and device ergonomics are expanding clinical applicability, while changes in where care is delivered are reshaping product preferences for single-use and reusable formats. Tariff dynamics and supply chain considerations add another dimension that influences sourcing and pricing strategies, necessitating proactive planning by manufacturers and purchasers alike.

Segmentation clarity-across product type, application, end user, and technology tiers-enables more precise go-to-market alignment, while regional nuance demands tailored approaches to regulatory compliance, reimbursement engagement, and service deployment. Companies that combine rigorous clinical collaboration, resilient operations, and flexible commercial models will be best equipped to translate innovation into sustained clinical adoption and commercial success.

As the landscape continues to evolve, ongoing engagement with clinicians, payers, and procurement stakeholders will be essential to ensure that product development and deployment strategies remain relevant, evidence-driven, and value-focused.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Angioscope Device Market, by Product Type

  • 8.1. Flexible
  • 8.2. Rigid

9. Angioscope Device Market, by Technology

  • 9.1. High Definition
    • 9.1.1. 4K
    • 9.1.2. Full HD
  • 9.2. Standard Definition
    • 9.2.1. SVGA
    • 9.2.2. VGA

10. Angioscope Device Market, by Application

  • 10.1. Diagnostic
    • 10.1.1. Gastrointestinal
    • 10.1.2. Respiratory
    • 10.1.3. Urological
  • 10.2. Therapeutic
    • 10.2.1. Cardiovascular
    • 10.2.2. Gastrointestinal
    • 10.2.3. Respiratory

11. Angioscope Device Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Specialty Clinics

12. Angioscope Device Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Angioscope Device Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Angioscope Device Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Angioscope Device Market

16. China Angioscope Device Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Becton, Dickinson and Company
  • 17.7. Boston Scientific Corporation
  • 17.8. Canon Medical Systems
  • 17.9. Cardinal Health
  • 17.10. Cook Medical
  • 17.11. Fujifilm Holdings Corporation
  • 17.12. GE Healthcare
  • 17.13. Hitachi Medical Corporation
  • 17.14. Johnson & Johnson Services, Inc.
  • 17.15. Karl Storz
  • 17.16. LivaNova PLC
  • 17.17. Medtronic PLC
  • 17.18. Olympus Corporation
  • 17.19. Philips Healthcare
  • 17.20. Shimadzu Corporation
  • 17.21. Siemens Healthineers
  • 17.22. Smith & Nephew PLC
  • 17.23. Stryker Corporation
  • 17.24. Terumo Corporation
  • 17.25. Vena Medica
  • 17.26. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANGIOSCOPE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ANGIOSCOPE DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ANGIOSCOPE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RIGID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RIGID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY 4K, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY 4K, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY 4K, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY FULL HD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY FULL HD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY FULL HD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY SVGA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY SVGA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY SVGA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY VGA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY VGA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY VGA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RESPIRATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY UROLOGICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY UROLOGICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY UROLOGICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GASTROINTESTINAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RESPIRATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 154. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 155. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 157. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 158. GCC ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 173. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 180. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 181. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 182. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 184. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 185. G7 ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 189. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 190. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 191. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 192. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 193. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 194. NATO ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANGIOSCOPE DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 200. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 201. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA ANGIOSCOPE DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 208. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY HIGH DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 209. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY STANDARD DEFINITION, 2018-2032 (USD MILLION)
  • TABLE 210. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY DIAGNOSTIC, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY THERAPEUTIC, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA ANGIOSCOPE DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)